Skip to content

Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary Strictures

Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary Strictures

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02615210
Acronym
SOCABS
Enrollment
3
Registered
2015-11-26
Start date
2015-11-30
Completion date
2018-11-30
Last updated
2023-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Tract Neoplasms

Brief summary

The purpose of this study is to determine if cholangioscopically-directed biopsies provide a higher diagnostic yield for malignancy in the setting of indeterminate biliary strictures when compared to standard means of sampling.

Detailed description

Biliary strictures in the absence of a mass are a clinical challenge, as current accepted means of sampling provide suboptimal accuracy. Both biliary brushings for cytology and fluoroscopically-directed biopsies produce highly-variable results. Endoscopic ultrasound with fine-needle aspiration has also been employed with variable results. An additional modality, using a single-operator cholangioscope during endoscopic retrograde cholangiopancreatography (ERCP) to obtain cholangioscopically-directed biopsies offers promise in increasing the yield of sampling. Initial observational studies have shown an improved diagnostic yield, but the technique has not been tested in a randomized, medical effectiveness study to better characterize its actual clinical impact. We aim to compare the technique of biopsy-on-biopsy derived sampling via single-operator cholangioscopy with standard fluoroscopically-directed biopsies and brushings in a pilot study. We also aim to perform a medical effectiveness study on the early use of single-operator cholangioscopically (SOC) in the evaluation of undiagnosed biliary strictures.

Interventions

DEVICESOC-directed biopsies using the SpyGlass System

The cholangioscopy procedure with the SpyGlass System is performed by a single operator with the SpyScope Access and Delivery Catheter positioned just below the operating channel of the duodenoscope. SpyBite Biopsy Forceps guided by the SpyScope Catheter are introduced and endoscopic-guided biopsy is taken at the level of the stricture. Target lesions will be identified under direct visualization using the SOC system, and 6-8 bites will be performed with the SpyBite forceps. Once SOC-directed biopsies are obtained, the SOC system will be withdrawn into the working channel of the duodenoscope and removed Patient will be contacted monthly to determine if they have undergone any additional procedures and to record potential adverse events.

Sponsors

Thomas Jefferson University
CollaboratorOTHER
University of Pennsylvania
CollaboratorOTHER
University of Pittsburgh Medical Center
CollaboratorOTHER
Geisinger Clinic
CollaboratorOTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
CollaboratorOTHER
Temple University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age greater than or equal to 18 years * Presence of indeterminate biliary strictures with clinical indications for ERCP. Strictures are considered indeterminate when evaluation including cross-sectional imaging is non-diagnostic. Patients who have previously undergone ERCP with sampling will be included, as well as those who have not previously undergone ERCP. * Strictures located above the intrapancreatic bile duct * The Subject's physician determines and ERCP is clinically indicated * Able to provide informed consent

Exclusion criteria

* Prior enrollment in the study or another study evaluating biliary strictures * Presence of extrahepatic malignancy or previously-diagnosed hepatocellular carcinoma * Pregnancy * At-risk populations including prisoners and mentally challenged * Unwilling to provide informed consent * Medically unfit to undergo ERCP * History of liver transplant

Design outcomes

Primary

MeasureTime frameDescription
Number of malignant diagnoses across hree-sample techniques (Spy bite, forceps biopsy, brushings)72 HoursAccuracy, sensitivity, and specificity of the three-sample technique (Spy bite, forceps biopsy, brushings) compared to the two-sample technique (forceps biopsy and brushing) in differentiating malignant from benign biliary strictures

Secondary

MeasureTime frameDescription
Number of patients who receive additional diagnostic studies without receiving a cancer diagnosis1 yearPatients who receive a repeat ERCP with sampling, cross-sectional imaging, EUS-FNA, IR-guided biopsies, laparoscopy
Endoscopic Satisfaction with SOC-directed biopsy2 hoursEndoscopist subjective outcomes using a Likert scale 1-5 * Ease of obtaining the biopsies * Confidence that the biopsy was taken from the target lesion * Confidence that an adequate sample was obtained from the biopsy * Clinical impression of malignant disease
Time from procedure to the initiation of treatment (in cases of malignancy)1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026